Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 18.51M P/E - EPS this Y -52.40% Ern Qtrly Grth -
Income -38.12M Forward P/E -0.76 EPS next Y 45.30% 50D Avg Chg -8.00%
Sales 107.84M PEG - EPS past 5Y - 200D Avg Chg -62.00%
Dividend N/A Price/Book 1.88 EPS next 5Y - 52W High Chg -88.00%
Recommedations 1.30 Quick Ratio 1.68 Shares Outstanding 69.33M 52W Low Chg 78.00%
Insider Own 3.85% ROA -14.52% Shares Float 30.04M Beta 1.11
Inst Own 74.80% ROE -194.69% Shares Shorted/Prior 364.49K/182.10K Price 0.27
Gross Margin 67.71% Profit Margin -35.34% Avg. Volume 657,350 Target Price 2.17
Oper. Margin -27.87% Earnings Date Nov 10 Volume 288,022 Change 9.83%
Venus Concept Inc. News
11/18/22 Venus Concept Announces Completion of $6.72 Million Private Placement Financing
11/10/22 Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results
10/19/22 Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/11/22 Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer
10/05/22 Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results
10/03/22 Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance
08/13/22 Time To Worry? Analysts Are Downgrading Their Venus Concept Inc. (NASDAQ:VERO) Outlook
08/12/22 Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance
08/08/22 Venus Concept Inc. (NASDAQ:VERO): Is Breakeven Near?
06/30/22 Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022
06/28/22 Insiders who bought stock earlier this year lose -US$216k as Venus Concept Inc. (NASDAQ:VERO) drops to US$29m
05/12/22 Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance
04/28/22 Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX
04/25/22 Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles
04/13/22 Palayan Resources (OTC: PLYN) Updates Due Diligence Progress for Acquisition of Global FinTech Company with Assistance from Small Business Development Group (OTC: SBDG)
03:05 PM Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
03/31/22 Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing
03/28/22 Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance
03/21/22 Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.

VERO Chatroom

User Image ArcticBuys Posted - 1 day ago

$VERO this is looking good, AH we should break .27. Let’s ride this up!

User Image Bgolf04 Posted - 1 day ago

$VERO https://www.cnbc.com/2022/12/02/heres-where-the-jobs-are-for-november-2022-in-one-chart.html?__source=iosappshare%7Ccom.apple.UIKit.activity.Message

User Image _Ynvestor_ Posted - 1 day ago

$VERO break fucking .27 wall and it is gone

User Image Bgolf04 Posted - 1 day ago

$VERO some decent sell orders up. Interesting

User Image _Ynvestor_ Posted - 1 day ago

$VERO it wants to takeoff

User Image MJMILL Posted - 1 day ago

$VERO ohhhh yeahhhh

User Image _Ynvestor_ Posted - 1 day ago

$VERO buckle up... it is going to be nice ride

User Image Elvira007 Posted - 1 day ago

$VERO 67% of float owned by 2 players after recent offering (These are current numbers from FINTEL). Top 2 are activists... I don't have to tell you what happens next... Kaboom Activist Investors (ALL CAPS) EW HEALTHCARE PARTNERS 36,181,956 40.6% MASTERS CAPITAL 22,999,173 26.5% $25m mkt cap company doing $100m in medical aesthetics and robotics worth a hell of a lot more. New CEO cleaning house and no liquidity issues all while backed by a TOP VC Healthcare fund (EW HEALTHCARE PARTNERS) Stock goes over $1.00 quickly (should have never gotten this low to begin with and back over $2.00 sometime before Q2/2023...

User Image _Ynvestor_ Posted - 1 day ago

$VERO up 1% LFG 🚀🚀🚀🚀🚀 😅

User Image jjjilll Posted - 2 days ago

$VERO how many shares are you holding?

User Image Bgolf04 Posted - 2 days ago

$VERO the ride up to 2/share is going to be fun.

User Image MJMILL Posted - 2 days ago

$VERO charts looking good 👀

User Image Elvira007 Posted - 2 days ago

$VERO That was me buying the last 50k shares into the close. On towards $0.50 next week and over $1.00 by January

User Image _Ynvestor_ Posted - 2 days ago

$VERO only up from here

User Image Elvira007 Posted - 2 days ago

$VERO Looks like this guy Natale from Aperture Ventures is selling like 50k shares a day to unload his 600k position. Likely for tax purposes is my best guess and likely gonna exit from board as well. Weakness should be over once he is gone....

User Image momoLong Posted - 2 days ago

$VERO L O L fraud stays fraud like SFB

User Image MJMILL Posted - 2 days ago

$VERO let’s see some movement today!

User Image MarketBeatInsiderTrades Posted - 11/30/22

Venus Concept Director Anthony Natale Sells $13,885.56 in $VERO https://www.marketbeat.com/i/538566

User Image Newsfilter Posted - 11/30/22

$VERO Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/6507854a32ba10cdf6a4c539b93fa8fa

User Image risenhoover Posted - 11/30/22

Insider Anthony Natale reports selling 102,859 shares of $VERO for a total cost of $26,182.72 https://fintel.io/n/us/vero/natale-anthony?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image Quantisnow Posted - 11/30/22

$VERO 📜 SEC Form 4: Natale Anthony sold $26,183 worth of shares (102,859 units at $0.25) https://quantisnow.com/i/3752014?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 11/30/22

$VERO [15s. delayed] filed SEC form 4: Director Natale Anthony: Disposed 102,859 of Common Shares at average price $0.25 between 2022-11- https://s.flashalert.me/YvSPEC

User Image _Ynvestor_ Posted - 11/30/22

$TOPS next one is $VERO insiders were loading big as well

User Image Elvira007 Posted - 11/30/22

$CABA Keep peeling off some to buy $MEIP and $VERO. Risk reward a little better there but hate selling anything even at $4+

User Image loganjuninyt Posted - 11/30/22

$REED geared to shoot up $MYO $VERO $THMO

User Image tickeron Posted - 11/30/22

If you are an active trader, pay attention! $VERO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://srnk.us/go/4195213

User Image _Ynvestor_ Posted - 11/30/22

$VERO i am in, time to wake up

User Image Elvira007 Posted - 11/30/22

$VERO OK. Although I am a long term holder here, in hindsight, I should have sold near $0.36 but find it hard to sell when I think $1.00 is fairly cheap. LOL. Monday morning quarterbacking.. Anyways, adding more here. Own more shares than total volume today so hopefully this tax loss selling is over soon....Will double my position if I can peel off some from my winners.. Good Luck

User Image Mikebouchard Posted - 11/30/22

$VERO time to go upside

User Image Quantisnow Posted - 11/30/22

$VERO 📜 SEC Form D filed by Venus Concept Inc. https://quantisnow.com/i/3749785?utm_source=stocktwits 45 seconds delayed.

Analyst Ratings
BTIG Buy Jun 24, 22
Stifel Hold Dec 9, 20
Oppenheimer Outperform Nov 17, 20
Ladenburg Thalmann Buy Oct 20, 20
BTIG Buy Jul 6, 20
Oppenheimer Perform Mar 31, 20
Maxim Group Buy Jan 9, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Natale Anthony Director Director Nov 22 Sell 0.28 154,284 43,200 744,366 11/25/22
Varghese Hemanth Jacob President/Chief Bus... President/Chief Bus. Officer Nov 18 Buy 0.20 250,000 50,000 250,000 11/22/22
DE SILVA RAJIV Officer Officer Nov 18 Buy 0.20 1,250,000 250,000 1,250,000 11/22/22
Della Penna Domenic Chief Financial Offi.. Chief Financial Officer Sep 16 Buy 0.59 60,000 35,400 126,663 09/19/22
Serafino Domenic Chief Executive Offi.. Chief Executive Officer Aug 30 Buy 0.33 75,000 24,750 1,008,758 08/31/22
PORTARO ROSS President Global Sal.. President Global Sales May 17 Buy 0.85 10,000 8,500 60,000 05/17/22
EW Healthcare Partners, L.P. 10% Owner 10% Owner Dec 15 Buy 1.25 3,920,000 4,900,000 16,337,856 12/17/21
BARRY RICHARD SCOTT Director Director Dec 15 Buy 1.25 3,920,000 4,900,000 16,337,856 12/17/21